These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A monkey model of tardive dyskinesia (TD): evidence that reversible TD may turn into irreversible TD. Kovacic B; Domino EF J Clin Psychopharmacol; 1982 Oct; 2(5):305-7. PubMed ID: 6890075 [TBL] [Abstract][Full Text] [Related]
6. Development of acute dystonia and tardive dyskinesia in cebus monkeys. Bárány S; Ingvast A; Gunne LM Res Commun Chem Pathol Pharmacol; 1979 Aug; 25(2):269-79. PubMed ID: 115074 [TBL] [Abstract][Full Text] [Related]
7. Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review. Domino EF Psychopharmacology Suppl; 1985; 2():217-23. PubMed ID: 2860660 [TBL] [Abstract][Full Text] [Related]
14. A monitoring test for the liability of neuroleptic drugs to induce tardive dyskinesia. Gunne LM; Bárány S Psychopharmacology (Berl); 1979 Jun; 63(3):195-8. PubMed ID: 39307 [TBL] [Abstract][Full Text] [Related]
15. Clozapine in tardive dyskinesia: observations from human and animal model studies. Tamminga CA; Thaker GK; Moran M; Kakigi T; Gao XM J Clin Psychiatry; 1994 Sep; 55 Suppl B():102-6. PubMed ID: 7961550 [TBL] [Abstract][Full Text] [Related]
16. Antidyskinetic action of 3-PPP, a selective dopaminergic autoreceptor agonist, in Cebus monkeys with persistent neuroleptic-induced dyskinesias. Häggström JE; Gunne LM; Carlsson A; Wikström H J Neural Transm; 1983; 58(3-4):135-42. PubMed ID: 6663299 [TBL] [Abstract][Full Text] [Related]